Early research (Phase 1)Study completedNCT00001060
What this trial is testing
A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30